1. Dr Ashleys to acquire Impact BioMedical in a strategic merger. 2. Transaction enhances IBO's market reach with Dr Ashleys' global capabilities. 3. New entity to be named Dr Ashleys Limited post-merger, listing on NYSE. 4. Leadership highlights innovative treatments and expanded global health impact. 5. Merger subject to shareholder approval and regulatory conditions.

1. C&S to acquire SpartanNash for $26.90 per share, $1.77 billion total. 2. Transaction offers 52.5% premium over SpartanNash's last closing price. 3. Merger aims to enhance efficiency and lower grocery prices in the U.S. 4. Transaction approved by both companies' Boards; expected to close late 2025. 5. SpartanNash's quarterly dividend of $0.22 per share will continue.

1. Torrid is launching a public offering of 10 million shares. 2. Proceeds will go to Selling Stockholders, not Torrid. 3. Torrid plans to repurchase $20 million of its own stock. 4. Concurrent Repurchase is subject to closing of the Offering. 5. Offering is backed by major financial institutions as book-running managers.

1. AVAV reported record revenue of $275.1 million for Q4 2025. 2. Fiscal year net income increased to $43.6 million, despite goodwill impairment of $18.4 million. 3. Company expects 2026 revenue between $1.9 billion and $2.0 billion from improved product demand. 4. Record fiscal year bookings reached $1.2 billion, reflecting strong market positioning. 5. Acquisition of BlueHalo enhances AVAV's defense technology portfolio and market competitiveness.

1. Net sales fell 9% year-over-year to $832.9 million. 2. Operating income slightly decreased to $66.4 million. 3. Net earnings increased to $55.7 million, showing strong performance amidst challenges. 4. Selected a quarterly dividend of $0.16 per share for September 2025. 5. Finalized acquisition of Sitem Group, enhancing market position in Europe.

1. VNET announces a $50 million share repurchase program signaling confidence. 2. The program allows repurchase of American depositary shares in open market. 3. Share repurchases may vary based on market conditions and regulations. 4. VNET operates in over 30 cities in China with diverse enterprise customers. 5. Future growth prospects are tied to data center market demand.

1. VNET raised 2025 revenue and EBITDA guidance based on strong Q1 performance. 2. Expected total revenues for 2025 are RMB9,150M to RMB9,350M, 11%-13% growth. 3. Adjusted EBITDA guidance increased to RMB2,760M to RMB2,820M, reflecting 14%-16% growth. 4. Robust growth driven by increased wholesale IDC client move-ins and operational efficiency. 5. The company operates extensively across China, serving a diverse client base.

1. LASE to acquire Beamer, enhancing laser system offerings and diversification. 2. Beamer generated $3-5 million in revenue from 2022 to 2024. 3. Acquisition enhances supply chain control and quality through U.S.-based operations. 4. Integration provides access to Beamer's 19 distribution centers across North America. 5. Transacting with Beamer increases LASE's customer base in various industries.

1. EHLD reported Q1 2025 revenues of $2.9 million, a 24.9% decrease. 2. Net income surged to $11.1 million, influenced by vessel sale gains. 3. Dividend of $0.14 declared, signaling confidence in future performance. 4. Pittas family reduced their shares to Marla Investments Inc., impacting governance. 5. Strategic review initiated, exploring growth and cooperation options.

1. Lulus announces a 1-for-15 reverse stock split effective July 3, 2025. 2. The stock split aims to meet Nasdaq listing requirements for minimum bid prices. 3. Approximate outstanding shares will decrease from 41 million to 2.8 million. 4. Lulus entered a Forbearance Agreement related to its Credit Agreement with Bank of America. 5. New financing options are being pursued before an August 15, 2025 deadline.